Nixing the X Waiver Hasn't Yet Vastly Expanded Buprenorphine Access
(MedPage Today) -- While the elimination of the X waiver increased the number of clinicians prescribing buprenorphine, it hasn't yet had a substantial impact on the number of patients taking the drug, according to an analysis of prescription data... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 25, 2024 Category: Psychiatry Source Type: news
CBT Beats Mindfulness for Prolonged Grief Disorder
(MedPage Today) -- Cognitive behavior therapy (CBT) bested mindfulness therapy for patients with prolonged grief disorder, a randomized clinical trial showed.
In Australian study of 100 patients, grief-focused CBT led to greater reductions in... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 24, 2024 Category: Psychiatry Source Type: news
Mid-Stage Win for Novel Depression Agent; 'Floordrobe' Disorder; CIA Mind Control
(MedPage Today) -- In the phase II SAVITRI study, once-daily treatment with an investigational, AMPA positive allosteric modulator (NBI-1065845) significantly reduced depression scores by day 28 in people with major depressive disorder who failed... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 24, 2024 Category: Psychiatry Source Type: news
Want to Be a Better Psychiatrist? Enter a Beauty Pageant!
(MedPage Today) -- With the elegant gowns, stylized hair, carefully applied makeup, and moments in the spotlight, beauty pageants have attracted longstanding criticism for being allegedly superficial competitions that foster narcissism. But beneath... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 20, 2024 Category: Psychiatry Source Type: news
Science Journals Under Fire; Infusion System Recall; Visual Impairment and Suicide
(MedPage Today) -- Note that some links may require registration or subscription.
House Republicans claimed during a public hearing that government scientists influenced scientific journals when it came to publishing COVID origin research. (Nature... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 18, 2024 Category: Psychiatry Source Type: news
'Satanic Panic' Psychiatrist Dies; Caplyta Depression Win; Esketamine After Birth
(MedPage Today) -- Bennett Braun, MD, the psychiatrist who promoted "Satanic Panic" when he claimed that dozens of his patients had discovered repressed memories of being tortured by satanic cults, and subsequently lost his license, died at age... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 17, 2024 Category: Psychiatry Source Type: news
Alzheimer's Agitation Relapse Delayed With Dextromethorphan-Bupropion
(MedPage Today) -- DENVER -- Dextromethorphan-bupropion (known as AXS-05) delayed time to relapse in patients with Alzheimer's-related agitation, according to a phase III trial presented here.
Compared with placebo, AXS-05 increased the time... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 17, 2024 Category: Psychiatry Source Type: news
Agitation Relapse Delayed With Dextromethorphan-Bupropion
(MedPage Today) -- DENVER -- Dextromethorphan-bupropion (known as AXS-05) delayed time to relapse in patients with Alzheimer's-related agitation, according to a phase III trial presented here.
Compared with placebo, AXS-05 increased the time... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 17, 2024 Category: Psychiatry Source Type: news
Idaho's Ban on Youth Gender-Affirming Care Has Families Scrambling for Solutions
(MedPage Today) -- Forced to hide her true self, Joe Horras' transgender daughter struggled with depression and anxiety until 3 years ago, when she began to take medication to block the onset of puberty. The gender-affirming treatment helped the... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 17, 2024 Category: Psychiatry Source Type: news
House Panel Says China Subsidizes Fentanyl Production to Fuel U.S. Crisis
(MedPage Today) -- China is fueling the fentanyl crisis in the U.S. by directly subsidizing the manufacturing of materials that are used by traffickers to make the drug outside the country, according to a report released Tuesday by a special House... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 17, 2024 Category: Psychiatry Source Type: news
It's the First Drug Shown to Slow Alzheimer's. Why Is It Off to a Slow Start?
(MedPage Today) -- The first drug shown to slow Alzheimer's disease hit the U.S. market over a year ago, but sales have lagged, major hospital systems have taken months to start using it, and some insurers have rejected coverage.
Doctors also... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 15, 2024 Category: Psychiatry Source Type: news
What Kate Middleton Reminds Us About the Role of Privacy in Healing
(MedPage Today) -- Maybe it's because my mother is from London, but I have always felt a certain type of kinship with the Royal Family. I remember getting up super early in the morning to watch the wedding of Kate -- the Princess of Wales -... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 15, 2024 Category: Psychiatry Source Type: news
Delirium and Dementia; Are Biosimilars Cheaper for Patients?
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 13, 2024 Category: Psychiatry Source Type: news
No Link Between GLP-1 Drugs and Suicide, Says European Regulator
(MedPage Today) -- The European Medicines Agency (EMA) found no evidence to support a causal link between GLP-1 receptor agonists and suicidal thoughts, a committee said on Friday following a 9-month review.
An investigation was launched in July... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 12, 2024 Category: Psychiatry Source Type: news
FDA OKs Anxiety Stimulation Device; Long-Term KarXT Data; Psilocybin Adverse Events
(MedPage Today) -- The FDA cleared Modius Stress, a non-invasive electrical stimulation device used to treat generalized anxiety disorder, said maker Neurovalens.
Youth with mood disorders were 30% less likely to acquire a driver's license than... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 10, 2024 Category: Psychiatry Source Type: news
